Search research articles
Contact Us
Filters
Showing results (1-10 of 71) with videos related to
Page
of 8
Sort By:
Current Pharmaceutical Design
|
June 27, 2015
Evolving Larger: Dosing Anti-Tuberculosis (TB) Drugs in an Obese World
Ronald G Hall
International Journal of Antimicrobial Agents
|
July 1, 2004
In vitro activity of parenteral Beta-lactams, levofloxacin and tobramycin alone or in combination against extended-spectrum Beta-lactamase producing Klebsiella pneumoniae
David S Burgess, Ronald G Hall
Diagnostic Microbiology and Infectious Disease
|
May 12, 2004
In vitro killing of parenteral beta-lactams against standard and high inocula of extended-spectrum beta-lactamase and non-ESBL producing Klebsiella pneumoniae
David S Burgess, Ronald G Hall
Infection and Drug Resistance
|
May 12, 2015
Profile of tedizolid phosphate and its potential in the treatment of acute bacterial skin and skin structure infections
Ronald G Hall, Heidi N Michaels
The Annals of Pharmacotherapy
|
February 15, 2007
Pharmacologic treatment options for nosocomial pneumonia involving methicillin-resistant Staphylococcus aureus
Darego O Maclayton, Ronald G Hall
Clinical Therapeutics
|
September 11, 2007
Simulated comparison of the pharmacodynamics of ciprofloxacin and levofloxacin against Pseudomonas aeruginosa using pharmacokinetic data from healthy volunteers and 2002 minimum inhibitory concentration data
David S Burgess, Ronald G Hall
Expert Review of Anti-Infective Therapy
|
May 10, 2014
Dosing of antibacterial agents in obese adults: does one size fit all?
Kenna D Payne, Ronald G Hall
Chest
|
September 18, 2007
Vancomycin dosing for methicillin-resistant staphylococcus aureus nosocomial pneumonia
Ronald G Hall, Beverley Adams-Huet
Innovations in Pharmacy
|
May 23, 2022
Pharmacists without Access to the EHR: Practicing with One Hand Tied Behind Our Backs
Deeatra S Craddock, Ronald G Hall
Expert Review of Anti-Infective Therapy
|
December 8, 2015
Dosing of antifungal agents in obese people
Kenna D Payne, Ronald G Hall
Page
of 8
Search research articles
Search
Showing results (1-10 of 71) with videos related to
Sort By:
Page
of 8
Current Pharmaceutical Design
|
June 27, 2015
Evolving Larger: Dosing Anti-Tuberculosis (TB) Drugs in an Obese World
Ronald G Hall
International Journal of Antimicrobial Agents
|
July 1, 2004
In vitro activity of parenteral Beta-lactams, levofloxacin and tobramycin alone or in combination against extended-spectrum Beta-lactamase producing Klebsiella pneumoniae
David S Burgess, Ronald G Hall
Diagnostic Microbiology and Infectious Disease
|
May 12, 2004
In vitro killing of parenteral beta-lactams against standard and high inocula of extended-spectrum beta-lactamase and non-ESBL producing Klebsiella pneumoniae
David S Burgess, Ronald G Hall
Infection and Drug Resistance
|
May 12, 2015
Profile of tedizolid phosphate and its potential in the treatment of acute bacterial skin and skin structure infections
Ronald G Hall, Heidi N Michaels
The Annals of Pharmacotherapy
|
February 15, 2007
Pharmacologic treatment options for nosocomial pneumonia involving methicillin-resistant Staphylococcus aureus
Darego O Maclayton, Ronald G Hall
Clinical Therapeutics
|
September 11, 2007
Simulated comparison of the pharmacodynamics of ciprofloxacin and levofloxacin against Pseudomonas aeruginosa using pharmacokinetic data from healthy volunteers and 2002 minimum inhibitory concentration data
David S Burgess, Ronald G Hall
Expert Review of Anti-Infective Therapy
|
May 10, 2014
Dosing of antibacterial agents in obese adults: does one size fit all?
Kenna D Payne, Ronald G Hall
Chest
|
September 18, 2007
Vancomycin dosing for methicillin-resistant staphylococcus aureus nosocomial pneumonia
Ronald G Hall, Beverley Adams-Huet
Innovations in Pharmacy
|
May 23, 2022
Pharmacists without Access to the EHR: Practicing with One Hand Tied Behind Our Backs
Deeatra S Craddock, Ronald G Hall
Expert Review of Anti-Infective Therapy
|
December 8, 2015
Dosing of antifungal agents in obese people
Kenna D Payne, Ronald G Hall
Page
of 8